ISO Certification for Peptide Labs: What It Covers and How to Verify It

For a peptide testing laboratory, the credential that matters is ISO/IEC 17025 accreditation, and it matters only for the tests listed on the lab’s scope. ISO 9001 certification describes a general quality management system. It does not show that a lab can perform a specific analytical method. GLP (Good Laboratory Practice) is a separate framework that governs how certain nonclinical studies are planned, recorded and reported. A batch Certificate of Analysis (COA) is the document where these layers meet. Vertex publishes available laboratory reports for research materials. This article explains how to evaluate credentials; it does not claim that Vertex or every laboratory report holds ISO accreditation.

For Research Use Only. Not for human or veterinary use.

TL;DR

• ISO 9001 certifies a general quality system. ISO/IEC 17025 accreditation evaluates a laboratory’s technical competence for specific tests, per NCSLI’s white paper on accreditation and certification.
• The scope of accreditation, not the certificate alone, states what a laboratory is accredited to do. Confirm that the method on your COA appears on it.
• GLP under 21 CFR Part 58 applies to nonclinical studies intended for FDA submission. Basic exploratory research with no such intent falls outside it.
• Verify any COA at three points: the accreditation body’s directory, the scope document, and the issuing laboratory’s own record of the report number.

Table of Contents

• What “ISO certification” means for a peptide laboratory
• Why the scope of accreditation is the document to read
• How to verify a peptide lab’s accreditation, step by step
• What a trustworthy COA contains
• Where GLP fits: 21 CFR Part 58
• How ISO accreditation, GLP and a batch COA relate
• Perspective: what we ask of every supplier, including ourselves
• Documentation from Vertex Labs
• Red flags in certification claims
• FAQ
• Sources

What “ISO certification” means for a peptide laboratory

Readers searching for “ISO certified peptide labs” usually combine two different things under one phrase. Certification and accreditation are not the same, and the difference decides how much weight a credential deserves.

ISO 9001 certification addresses a management system: documented procedures, internal audits, corrective actions. A company of any kind can hold it. NCSLI’s white paper describes it as covering a general quality management system, in contrast to accreditation, which assesses technical competence.

ISO/IEC 17025 accreditation is the standard titled “General requirements for the competence of testing and calibration laboratories.” It is the main standard used by testing and calibration laboratories, and in the United States accreditation bodies such as A2LA and ANAB assess labs against it. NCSLI notes that assessment uses criteria developed to determine technical competence, with specialist assessors reviewing staff competence, validity of methods, measurement traceability, measurement uncertainty, equipment calibration, the testing environment, sample handling and quality assurance of data.

For a researcher buying peptides, the practical consequence is straightforward. NCSLI advises that suppliers looking for competent testing facilities should ensure those facilities are accredited to ISO/IEC 17025 with a scope appropriate for the testing required. A logo reading “ISO certified” on a website answers a different question.

The U.S. government also runs a program of this kind. NIST’s National Voluntary Laboratory Accreditation Program (NVLAP), described in NIST Handbook 150, provides voluntary accreditation to testing and calibration laboratories. Accreditation is acknowledged by a Certificate of Accreditation and a Scope of Accreditation, which details the specific test methods or services for which a laboratory has been accredited.

Why the scope of accreditation is the document to read

Accreditation is not a blanket endorsement of everything a laboratory does. According to NIST Handbook 150, the scope for tests identifies the materials or products tested, the methods used and the tests performed. The scope is the authoritative statement of what a lab is accredited to do. ILAC’s Guideline for describing Scopes of Accreditation defines it as the formal statement, issued by an accreditation body, of the specific conformity assessment activities a laboratory is accredited and competent to perform. A laboratory cannot change the activities covered without advising the accreditation body and undergoing some level of assessment.

For peptide work, a scope line may name the testing field, the material type, the analyte or property measured and the technique. Three situations show why this matters:

1. A lab is accredited, but not for your method. A laboratory may hold accredited chemical testing by liquid chromatography for one class of materials and have no accredited scope for peptide identity by high-resolution mass spectrometry. An unlisted method must not be assumed to fall within accreditation; check any flexible-scope provisions and the report’s statement of accredited status.
2. The matrix differs. A lab accredited for one product matrix is not automatically accredited for another. The scope must list the relevant method and matrix.
3. The scope is flexible rather than fixed. Some laboratories hold a flexible scope, which lets them adapt or introduce methods within a defined class under internal controls. A fixed scope names each method. Both are recognized approaches, but they differ in how much of a given result was individually assessed by an outside party. If your COA depends on a custom method, ask which kind of scope applies.

The method terms used in peptide characterization, such as specificity, linearity, accuracy, precision, range and robustness, come from ICH Q2 validation vocabulary. When a method is non-standard or modified, ISO/IEC 17025 expects the lab to validate it for its intended use. For a standard published method, the lab must verify that it can perform it properly. Those are the questions a technical reviewer asks of any analytical report.

How to verify a peptide lab’s accreditation, step by step

Public directories provide a starting point; the time needed depends on the scope and whether the issuing laboratory must clarify a report. Each step below shows where it commonly goes wrong.

Step 1: Get the accreditation body and certificate number

Ask for the accreditation number and the name of the body that issued it, typically A2LA or ANAB in the United States, or NVLAP for NIST-administered accreditation. If a supplier or lab gives only a logo, treat the accreditation as unconfirmed.

Step 2: Search the body’s public directory

Use the accreditation body’s own directory, not a copy on the lab’s website. Search by lab name or number and check that the status is current. Accreditation runs on a cycle, and expiry matters: an A2LA scope document, for example, prints the date the certificate was presented and the date it is valid to, along with a revision date.

Step 3: Download the scope and find your method

Open the scope document and look for the method named on your COA, for example HPLC purity quantification or LC-MS identity confirmation, and the material type. If the technique is absent, ask whether a flexible scope covers it; otherwise treat its accredited status as unconfirmed. Also check the measurement range for quantitative tests.

Step 4: Match the report to the lab’s own records

A PDF that looks professional proves little. Confirm the report number directly with the issuing laboratory, through a verification portal if it has one or by contacting the lab. A mismatch requires clarification from the issuing laboratory; it may reflect a revision, transcription or an authenticity problem and is not, by itself, proof of falsification. For Vertex materials with an available batch-specific COA, match the report to the exact presentation and lot, then verify it with the issuing laboratory where verification is available. If a report is not assigned or published, request the documentation rather than assuming that the material has been covered.

Step 5: Record what you checked

Save the directory screenshot, the scope document with its revision date and the report number in your lab notebook or procurement file. Auditors and journal reviewers ask for evidence of supplier qualification, and a dated record answers them. Our guides on peptide vendor evaluation criteria and the peptide supplier audit checklist extend this routine to supplier qualification as a whole.

What a trustworthy COA contains

Accreditation status is one element of the report. A reviewer should also expect the following, which together let a third party reconstruct how the result was produced:

This table is an enhanced procurement checklist, not a claim that every item must appear on every ISO/IEC 17025 report. Some supporting records, such as instrument serial numbers, reference-standard lots and raw data, may be retained by the laboratory rather than printed on the COA. Request them when the research purpose requires them. Missing attachments alone do not prove an invalid or fraudulent report.

Vertex Labs supplies research-use-only materials. Review the selected product presentation and its available batch-specific COA; documentation availability and reported results vary by lot. A published purity standard does not replace the findings of an individual laboratory report. The testing standards page states that accreditation must be supported separately by current credentials and the relevant scope.

Where GLP fits: 21 CFR Part 58

Good Laboratory Practice is frequently confused with ISO accreditation. They answer different questions. ISO/IEC 17025 asks whether a testing laboratory is technically competent for given methods. GLP asks whether a nonclinical study was planned, conducted, monitored, recorded and reported in a way that makes its data reliable for a regulatory decision.

When GLP applies

According to 21 CFR Part 58, the regulation applies to a nonclinical laboratory study in which a test article is studied prospectively in a test system under laboratory conditions to determine its safety properties, where results are intended to be submitted to or held for inspection by FDA as part of a research or marketing permit application. Basic exploratory research with no such regulatory intent falls outside GLP scope. For sponsors filing an IND, 21 CFR 312.23(a)(8)(iii) requires the application to state, for each covered nonclinical study, whether it complied with GLP or, if not, to give a brief statement of the reason.

ANAB’s SR 2432, effective May 13, 2022, describes Part 58 as prescribing GLP for nonclinical studies that support or are intended to support applications for research or marketing permits for products regulated by FDA. That includes food and color additives, animal food additives, human and animal drugs, medical devices, biological products and electronic products.

Most academic peptide characterization work, such as assay development or analytical comparisons of batches, is exploratory and not GLP-governed. Whether a given study is in scope is a question for your institution’s regulatory affairs or quality assurance office, and for the sponsor if one exists. Research-use-only status is not a legal exemption of any kind, and this article makes no legal determination for any study.

The documentation a GLP study maintains

When GLP does apply, the documentation set is specific. The elements below are drawn from Part 58 in the current eCFR and ANAB reference:

• Written protocol. Signed before the study starts, with amendments approved before they are implemented.
• Raw data. Recorded at the time of observation, attributable to the person who made the entry, with corrections made so the original entry stays legible. Assess whether the electronic records and signatures fall within 21 CFR Part 11; its applicability should be determined for the records and system in question.
• Independent quality assurance. Under 21 CFR 58.35, every testing facility maintains a quality assurance unit entirely separate from and independent of the personnel directing and conducting the study. The unit keeps copies of protocols, maintains a master schedule, conducts periodic inspections, immediately notifies the study director and management of any problem likely to affect study integrity, and reviews the final report.
• Final report. Under §58.185, the report includes the facility name and address, study initiation and completion dates, statistical methods, stability of test and control articles, circumstances that may have affected data quality, the names of the study director and other scientists, storage locations for specimens and raw data, and a signed statement from the quality assurance unit.
• Archive and retention. Under §58.190, raw data, documentation, protocols, final reports and specimens generated by a nonclinical study must be retained, with exceptions for certain specimens. The retention period is governed by §58.195, and it depends on whether the study supports an application and what FDA does with it. Confirm the period for your study with your quality assurance unit.

The current Part 58 text sets out study, quality-assurance and retention requirements. A routine COA is not a substitute for the complete documentation of an applicable GLP study.

How ISO accreditation, GLP and a batch COA relate

The three are layers, not substitutes.

A batch COA can be issued by an accredited laboratory without any GLP involvement, because GLP governs studies and not routine analytical certificates. A GLP study, in turn, depends on the characterization of its test article. Part 58 expects a final report to address the stability of test and control articles, which means the identity, purity and storage record of the material you used becomes part of your study documentation. That is where a lot-specific COA, filed with its lot number and tied to a verified scope, earns its place in a regulated file.

See our guide to maintaining peptide compliance in a regulated lab for how to organize that file, and our article on why lab accreditation matters for peptide studies for the accreditation side.

Perspective: what we ask of every supplier, including ourselves

We treat accreditation as a scope question. A credential line on a web page tells a researcher little until the scope is open in front of them and the method on the COA is found in it.

Our position is that documentation should let a reviewer work backward from a result to a lot, a method, an instrument and an issuing laboratory. That is why we publish batch-specific COAs from independent third-party laboratory testing, and why we encourage the researchers we supply to confirm report numbers with the issuing laboratory and to file those confirmations with the purchase record.

For institutions with regulated workflows, we support procurement with lot-level documentation and bulk options, so that the same traceable batch can serve a study from the first assay to the final report. Our research-use-only compounds are supplied for laboratory work only, and we make no regulatory claims about them beyond the documentation we provide.

Vertex Labs Editorial Team

Documentation from Vertex Labs

Vertex Labs supplies research-use-only materials. Review the selected product presentation and its available batch-specific COA; documentation availability and reported results vary by lot. A published purity standard does not replace the findings of an individual laboratory report. Custom synthesis and institutional bulk requests can be discussed with Vertex, with scope and documentation confirmed for each order.

For sequence-level questions before you order, our peptide sequence verification guide explains what identity documentation to request. For Research Use Only. Not for human or veterinary use.

Red flags in certification claims

Several patterns should prompt a closer check before you rely on a result:

• A certification logo with no number or named accreditation body.
• ISO 9001 presented as if it were proof of analytical competence.
• Accreditation of the lab named, but no scope document offered, or a scope that does not list the method on the report.
• An expired or superseded scope. Check the validity dates and revision date.
• A COA that the issuing laboratory cannot confirm, no matter how polished the PDF looks.
• A testing laboratory that is financially controlled by the vendor whose product it tests.
• A report with no raw data, such as no chromatogram or mass spectrum attached.

None of these requires specialist knowledge to spot. They require only that the reader opens the directory and the scope instead of relying on the badge.

FAQ

Is there such a thing as an ISO certified peptide lab?

The more accurate term is an ISO/IEC 17025 accredited laboratory. Certification generally refers to management systems such as ISO 9001, while accreditation is a body’s formal recognition of technical competence for listed tests. Look for the accreditation body, the number and a scope that names your method.

Does ISO/IEC 17025 accreditation mean every result from that lab is accredited?

No. Accreditation covers the test methods and materials on the scope. An unlisted method is not automatically covered; verify any flexible-scope provisions with the laboratory or accreditation body. Confirm that the scope names the technique and the material on your report.

Do I need GLP documentation for peptide research?

Only when the study falls under 21 CFR Part 58, meaning a nonclinical laboratory study whose results are intended for submission to or inspection by FDA in support of a permit application. Exploratory research with no such intent falls outside that scope. Your institution’s quality assurance or regulatory office decides how a specific study is classified.

Is a batch COA the same as GLP documentation?

No. A COA documents the identity and purity of a specific lot, while GLP documentation records how a study was planned, conducted and reported. A lot-specific COA can be filed as part of the characterization record for a study’s test article.

How do I confirm a COA is genuine?

Contact the issuing laboratory with the report number and ask it to confirm that the report exists and matches your copy. Then check the laboratory’s accreditation status and scope in the accreditation body’s directory. Ask the issuing laboratory to resolve any mismatch and identify the authoritative revision before relying on the result.

Checking Vertex batch evidence

Open the current catalog and COA directory, then match the selected presentation and vial lot to the complete laboratory report. For example, the MOTS-C product page lists separate reports for its 20 mg and 40 mg presentations. A report for one presentation does not verify another or establish which lot is currently shipping. Purity results do not establish sterility, counterion composition, accreditation or clinical suitability unless those matters are separately documented.

For lawful laboratory research only. Purchasers must meet Vertex’s eligibility requirements, including age 21 or older. Sales are directed to the United States and Puerto Rico. Not for human or veterinary use.

Sources

• NIST Handbook 150: 2020 Edition Update 1
• NCSLI: Laboratory Accreditation or ISO 9001 Certification?
• ISO/IEC 17025 overview
• ILAC Guideline for describing Scopes of Accreditation
• A2LA scope of accreditation document, Cert. No. 2731.01
• eCFR: 21 CFR Part 58
• ANAB SR 2432

Recommended

• Why Lab Accreditation Matters for Peptide Studies
• Peptide Vendor Evaluation Criteria for Researchers
• Peptide Supplier Audit Checklist: When HPLC Is Not Enough
• Peptide Manufacturing Quality Benchmarks: A Researcher’s Guide